false 0001463972 0001463972 2024-08-14 2024-08-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported) August 14, 2024

 

VUZIX CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware

(State or other jurisdiction of incorporation)

 

001-35955 04-3392453
(Commission File Number) (IRS Employer Identification No.)

 

25 Hendrix Road, Suite A,

West Henrietta, New York 14586

(Address of principal executive offices)(Zipcode)

 

(585) 359-5900

(Registrant’s Telephone Number, Including Area Code)

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class:   Trading Symbol(s)   Name of each exchange on which registered:
Common Stock, par value $0.001   VUZI   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 2.02 Results of Operations and Financial Condition.

 

On August 14, 2024, Vuzix Corporation (the “Company”) issued a press release announcing the Company’s financial results for the period ended June 30, 2024. The press release is attached hereto as Exhibit 99.1.

 

In accordance with General Instruction B.2 of Form 8-K, the information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

99.1Press Release

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: August 15, 2024 VUZIX CORPORATION
     
     
By: /s/ Grant Russell
   

Grant Russell

Chief Financial Officer

 

 

 

Exhibit 99.1

   

  

Vuzix Reports Second Quarter 2024 Results

 

 

ROCHESTER, N.Y., August 14, 2024 - Vuzix® Corporation (NASDAQ: VUZI) (“Vuzix” or the “Company”), a leading supplier of Smart Glasses and Augmented Reality (AR) technologies and products, today reported its second quarter results for the three months ended June 30, 2024.

 

In our second quarter of 2024, Vuzix underpinned key end-customer and strategic relationships within the enterprise, consumer, and defense markets centered around business opportunities that are expected to have a meaningful impact on both our balance sheet and top-line revenue growth over the back half of 2024 and into 2025,” said Paul Travers, President and CEO of Vuzix. “At the same time, we have reduced our annual cost structure going forward by $8M as compared to 2023 through headcount reductions, tighter cost controls and a voluntary and widely adopted salary reduction program that offers staff, directors and management restricted stock or stock options in lieu of foregoing up to 50% of their base salaries."

 

The following table compares condensed elements of the Company’s unaudited summarized Consolidated Statements of Operations data for the three months ended June 30, 2024 and 2023, respectively:

 

   For Three Months Ended June 30 
   ($000s except per share amounts) 
   2024   2023 
Sales:          
Sales of Products  $601   $4,425 
Sales of Engineering Services   491    266 
Total Sales   1,093    4,691 
           
Total Cost of Sales   1,426    3,718 
           
Gross Profit (Loss)   (333)   972 
Gross Profit (Loss) %   (30)%   21%
           
Operating Expenses:          
Research and Development   2,359    2,837 
Selling and Marketing   2,238    2,510 
General and Administrative   4,492    4,260 
Depreciation and Amortization   1,188    973 
Impairment of Patents and Trademarks   30,120    - 
           
Loss from Operations   (40,730)   (9,608)
           
Total Other Income (Expense)   118    563 

Net Loss

   (40,612)   (9,045)
           
Loss per Common Share  $(0.62)  $(0.14)
           

 

 

 

Second Quarter 2024 Financial Results

 

For the three months ended June 30, 2024, total revenues decreased by 77% to $1.1 million versus $4.7 million for the comparable period in 2023. The decrease in total revenues was due to lower product sales and specifically reduced unit sales of M400 smart glasses as compared to the prior year’s period, when an Asian distributor placed a significant order. Engineering services revenues were $0.5 million for the three months ended June 30, 2024 as compared to $0.3 million in the prior year’s quarter.

 

There was an overall gross loss of $0.3 million for the three months ended June 30, 2024 as compared to a gross profit of $1.0 million or 21% of revenue for the same period in 2023. The loss was the result of lower revenues to absorb many of the company’s relatively fixed manufacturing overhead costs as compared to the 2023 period.

 

Research and Development expense was $2.4 million for the three months ended June 30, 2024, versus $2.8 million for the comparable 2023 period, a decrease of approximately 17%. This decrease was primarily due to reduced external development costs and salary and benefits related expenses.

 

Selling and Marketing expense was $2.2 million for the three months ended June 30, 2024, versus $2.5 million for the comparable 2023 period, a decrease of approximately 11%. This decrease was primarily due to lower advertising and tradeshow spending and reduced salary and benefits expenses.

 

General and Administrative expense for the three months ended June 30, 2024 was $4.5 million versus $4.3 million for the comparable 2023 period, an increase of approximately 5%. This increase was largely due to higher accounting and auditing fees related to the Company’s 2023 audit.

 

Included in operating expenses for the three months ended June 30, 2024 was a $30.1 million non-cash charge related to the carrying value of the Company’s technology license and equity investment in Atomistic, which was written-off due to the termination of the Company’s exclusive license agreement, effective June 30, 2024.

 

The net loss for the three months ended June 30, 2024 was $40.6 million, or $0.62 cents per share versus a net loss of $9.0 million, or $0.14 for the comparable period in 2023.

 

The cash net loss, excluding working capital changes, a non-GAAP measure, was $5.9M for the second quarter of 2024 versus $4.5M for the comparable 2023 period. As of June 30, 2024, the Company maintained cash and cash equivalents of $9.9 million and an overall working capital position of $22.1 million.

 

Management Outlook

 

“We expect to see top-line revenue improvement over the second half of 2024.  We have a number of enterprise accounts that are on a path to volume deployment of our smart glasses and solutions within their operations to deliver improved productivity, lower onboarding times and fewer errors. Our OEM business opportunities remain robust; we have a backlog of business to deliver against and we expect at least one of our defense contractors and one of our commercial enterprise customers to move into production later this year. On the waveguide manufacturing front, we will continue to implement process improvements as we prepare to ramp production to support underlying demand from partners and the broader markets," said Mr. Travers.    

 

 

 

 

Conference Call Information

 

Date: Wednesday, August 14, 2024

Time: 4:30 p.m. Eastern Time (ET)

Dial-in Number for U.S. & Canadian Callers: 877-709-8150

Dial-in Number for International Callers (Outside of the U.S. & Canada): 201-689-8354

 

A live and archived webcast of the conference call will be available on the investor relations page of the Company's website at: https://ir.vuzix.com/ or directly at https://event.choruscall.com/mediaframe/webcast.html?webcastid=RkRQYjCk.

 

Participating on the call will be Vuzix’ Chief Executive Officer and President Paul Travers and Chief Financial Officer Grant Russell, who together will discuss operational and financial highlights for the quarter ended June 30, 2024.

 

To join the live conference call, please dial into the above referenced telephone numbers five to ten minutes prior to the scheduled conference call time.

 

A telephonic replay will be available for 30 days, starting on August 14, 2024, at approximately 5:30 p.m. (ET). To access this replay, please dial 877-660-6853 within the U.S. or Canada, or 201-612-7415 for international callers. The conference replay ID# is 13748253.

 

About Vuzix Corporation

 

Vuzix is a leading designer, manufacturer and marketer of Smart Glasses and Augmented Reality (AR) technologies and products for the enterprise, medical, defense and consumer markets. The Company’s products include head-mounted smart personal display and wearable computing devices that offer users a portable high-quality viewing experience, provide solutions for mobility, wearable displays and augmented reality, as well OEM waveguide optical components and display engines. Vuzix holds more than 375 patents and patents pending and numerous IP licenses in the fields of optics, head-mounted displays, and augmented reality Video Eyewear field. Moviynt, an SAP Certified ERP SaaS logistics solution provider, is a Vuzix wholly owned subsidiary. The Company has won Consumer Electronics Show (or CES) awards for innovation for the years 2005 to 2024 and several wireless technology innovation awards among others. Founded in 1997, Vuzix is a public company (NASDAQ: VUZI) with offices in: Rochester, NY; and Kyoto and Tokyo, Japan. For more information, visit the Vuzix website, Twitter and Facebook pages.

 

 

 

 


Forward-Looking Statements Disclaimer

 

Certain statements contained in this news release are "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. Forward-looking statements contained in this release relate to, among other things, the timing of new product releases, opportunities related to market disruptions regarding smart glasses demand, R&D project successes, smart glasses pilot to roll-out conversion rates, existing and new engineering services and conversion to volume production OEM programs, future revenue and operating results, the amount and impact of operating expense cash reductions, and the Company's leadership in the Smart Glasses and AR display industry. They are generally identified by words such as "believes," "may," "expects," "anticipates," "should" and similar expressions. Readers should not place undue reliance on such forward-looking statements, which are based upon the Company's beliefs and assumptions as of the date of this release. The Company's actual results could differ materially due to risk factors and other items described in more detail in the Company's Annual Reports and other filings with the United States Securities and Exchange Commission and applicable Canadian securities regulators (copies of which may be obtained at www.sedar.com or www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.

 

Investor Relations Contact

 

Ed McGregor, Director of Investor Relations

Vuzix Corporation

ed_mcgregor@vuzix.com

Tel: (585) 359-5985

 

Vuzix Corporation, 25 Hendrix Road, West Henrietta, NY 14586 USA,

Investor Information – IR@vuzix.com www.vuzix.com

 

 

 

v3.24.2.u1
Cover
Aug. 14, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Aug. 14, 2024
Entity File Number 001-35955
Entity Registrant Name VUZIX CORPORATION
Entity Central Index Key 0001463972
Entity Tax Identification Number 04-3392453
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 25 Hendrix Road
Entity Address, Address Line Two Suite A
Entity Address, City or Town West Henrietta
Entity Address, State or Province NY
Entity Address, Postal Zip Code 14586
City Area Code 585
Local Phone Number 359-5900
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001
Trading Symbol VUZI
Security Exchange Name NASDAQ
Entity Emerging Growth Company false

Vuzix (NASDAQ:VUZI)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024 Plus de graphiques de la Bourse Vuzix
Vuzix (NASDAQ:VUZI)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024 Plus de graphiques de la Bourse Vuzix